MLICM
PROK icon

Metropolitan Life Insurance Company (MetLife)’s ProKidney PROK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,429
Closed -$15.7K – 2379
2023
Q3 		$15.7K Hold
3,429
– – ﹤0.01% 2004
2023
Q2 		$38.4K Buy
+3,429
New +$36.5K ﹤0.01% 1584

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $112M AUM 3.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PROK Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ProKidney (PROK) in Q4 2023, closing a stake of 3,429 shares — an estimated $15.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PROK in Q2 2023 and held it in 2 quarters. The position peaked at $38.4K in Q2 2023. 61 funds tracked by Wall St. Rank hold PROK as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ProKidney position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,429 ProKidney shares in Q4 2023, an estimated $15.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ProKidney in Q2 2023 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ProKidney position peaked at $38.4K in Q2 2023.
  • 61 funds tracked by Wall St. Rank held ProKidney as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.